COMMUNIQUÉS West-GlobeNewswire
-
RAMSAY SANTE : Non audited consolidated financial statements for FY24
05/08/2024 - 17:35 -
RAMSAY SANTE : Eléments financiers consolidés non audités à fin juin 2024
05/08/2024 - 17:35 -
Report: At $686,000 Orthopedic Surgeons Earn The Highest Physician Starting Salary
05/08/2024 - 16:00 -
Baylor Genetics and Baylor College of Medicine Announce New Lab Agreement with Shared Commitment to Innovation and Rapid Implementation to get Critical Testing to Patients
05/08/2024 - 16:00 -
OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024
05/08/2024 - 15:08 -
Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
05/08/2024 - 15:01 -
GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE
05/08/2024 - 15:00 -
NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility
05/08/2024 - 15:00 -
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024
05/08/2024 - 15:00 -
Dror Ortho-Design, Inc. Launches ZSMILE User Experience Trial
05/08/2024 - 15:00 -
AFB Names 2024 Migel Medal Honorees
05/08/2024 - 14:54 -
Merus annonce ses résultats financiers pour le deuxième trimestre 2024 et fait le point sur ses activités
03/08/2024 - 18:36 -
NTG Nordic Transport Group acquires SCHMALZ+SCHÖN Holding GmbH
02/08/2024 - 23:55 -
FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C
02/08/2024 - 23:50 -
Avicanna Announces Changes of Auditors
02/08/2024 - 23:30 -
Digicann Ventures and 3Win Corp. Sign Binding LOI for Proposed RTO Transaction
02/08/2024 - 23:05 -
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
02/08/2024 - 22:30 -
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02/08/2024 - 22:30 -
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/08/2024 - 22:30
Pages